CARM1 and Miyoshi myopathy: Consistently, CARM1 was highly expressed in MM patients, and the expression level of CARM1 was significantly higher in stage III patients than in stage I-II patients (P < 0.05) (Fig. 1c), indicated that CARM1 is proportional to the severity of MM.